Genomic & Biopharma News

Japanese scientists discover new potential treatment for septic shock
Sepsis is a life-threatening condition due to excessive immune responses to infection that damages the patient's own tissues and organs.
News Medical Life Sciences, 2017-02-09 11:23:32

Novo Nordisk backs Denmark’s bid to host EMA post-Brexit
Novo Nordisk backs Denmark’s bid to host EMA post-Brexit nick.paul.taylor Thu, 02/09/2017 - 06:04
Fierce Biotech, 2017-02-09 11:04:42

NICE backs targeted breast cancer therapy
Cost regulators for National Health Service treatments in England and Wales are backing controlled use of targeted breast cancer radiotherapy treatment alongside further research.
PharmaTimes, 2017-02-09 11:03:01

‘Smokeless Doesn't Mean Harmless’ effort fails to provide much-needed information on product risks
Last spring, the U.S. Food and Drug Administration unveiled a $36 million ad campaign focused on the dangers of smokeless tobacco use among rural teens.
News Medical Life Sciences, 2017-02-09 10:59:40

Neuroscience range by Amsbio covers a variety of tools to help neuroscience research
AMSBIO has published a new 25-page Neuroscience catalogue that details its extensive range of specific tools and reagents to enable researchers stay at the forefront of their field.
News Medical Life Sciences, 2017-02-09 10:59:31

GSK books solid results on weak pound, new products
GlaxoSmithKline has booked a 36 percent rise (14 percent at constant exchange rates) in core profit to £7.8 billion for 2016, driven by a 17 percent leap (6 percent at CER) in revenues to £27.9 billion.
PharmaTimes, 2017-02-09 10:54:15

Bayer/Janssen’s Xarelto artery disease trial stopped early
Bayer/Janssen's bloodthinner Xarelto has shown clear efficacy in preventing major cardiovascular events (MACE) in patients with coronary or peripheral artery disease taking part in the COMPASS trial, prompting an early halt to the late-stage study.
PharmaTimes, 2017-02-09 10:38:28

CRT, Tusk and UCL form immuno-oncology pact
Cancer Research Technology, Tusk Therapeutics and UCL (University College London) have have signed a pact to research, develop and commercialise an antibody-based therapeutic against a target known to play a key role in immune suppression in cancer.
PharmaTimes, 2017-02-09 10:31:24

UCLA cardiology expert provides ten heart healthy tips for Valentine's Day
While boxes of decadent chocolates treats, celebratory champagne and romantic high-calorie dinners may dance in your mind as a way to celebrate Valentine's Day, your heart may be pining for something else. With Valentine's Day just around the corner, it is a great time to look at the state of your heart.
News Medical Life Sciences, 2017-02-09 10:17:04